We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Fox Chase Cancer Center researchers identified a cholesterol-sharing mechanism that could become a new therapeutic target for pancreatic cancer. Preclinical experiments suggest blocking the mechanism may slow tumor growth and reduce immune suppression.